Pharma’s New Patient Access Website: A Signal for Insurers?
PhRMA introduces an online platform connecting patients with discounted pharmaceuticals as the U.S. government pressures drug companies to reform pricing and distribution.
Medicare Drug Price Negotiations Yield Significant Savings for 15 Key Medications
Pharmaceutical companies agree to reduce Medicare prices for 15 prescription drugs, potentially saving billions in taxpayer and patient costs under new negotiation rules starting in 2027.
Pharma Pulse Podcast Delivers Insights on Pharmaceutical Access and Innovation
Stay informed with Pharma Pulse podcast, delivering the latest trends in pharmaceutical access, supply chain logistics, data technology, and healthcare innovation for industry professionals.
U.S. Takes Steps to Lower Drug Prices Through Executive Order and Medicare Negotiations
President Trump's executive order and CMS initiatives mark significant moves to reduce drug prices through broadened Medicare price negotiations including Part B drugs, impacting pharmaceutical industry dynamics and regulatory compliance.
Trump Orders 30-Day Deadline for Drugmakers to Lower U.S. Prescription Prices
President Trump signs an executive order setting a 30-day deadline for drugmakers to lower prescription drug prices in the U.S. or face new federal limits tied to international prices.
Trump Administration to Reintroduce 'Most Favored Nation' Drug Pricing for Medicare
The Trump administration plans to reintroduce a 'most favored nation' drug pricing model for Medicare, aiming to align U.S. drug prices with lower international rates. This strategy faces industry opposition but could complement existing Medicare drug price negotiations to reduce costs.
Medicare for All Act Reintroduction Targets Universal Health Coverage Reform
The Medicare for All Act aims to expand Medicare to cover all Americans comprehensively, eliminating premiums and deductibles while addressing health care affordability and systemic inefficiencies.